National Cheng Kung University Hospital
Tainan, 704, Taiwan
NCT Number: NCT03680950
A monitoring system was developed for detecting upper gastrointestinal (UGI) rebleeding. This system consists of (1) a tiny endoscopy, (2) a wearable device, and (3) a software. The endoscopy is inserted to UGI tract via nasal cavity and then stayed there for 3 days. The wearable device is set to regularly receive the pictures from the endoscopy and sent to the software, which is able to automatically analyze whether the rebleeding occurs. This study aims to test the feasibility and efficacy of the monitoring system.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Tainan, 704, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will wear a monitoring system consisting of a tiny endoscopy and a mobile device. The endoscopy is inserted to upper gastrointestinal tract via nasal cavity and the mobile device is set to take and send images from the endoscopy to a server for analyzing if the abnormal condition occurs.
Time frame: 3 days
The real-time upper gastrointestinal monitoring system is compared with the current monitoring index. The efficacy is estimated by which monitoring method finding the upper gastrointestinal rebleeding first.
Time frame: 3 days
The accuracy of the current monitoring index and the real-time upper gastrointestinal monitoring system is compared. The accuracy is estimated by calculating the ratio of the number of making false alarm and the number of finding re-bleeding right.
National Cheng-Kung University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06077916
Digestive System Diseases, Gastrointestinal Diseases
Bucharest, Romania
View Trial DetailsNCT06350864
Digestive System Diseases, Gastrointestinal Diseases
Cairo, Egypt
View Trial DetailsNCT06297954
Digestive System Diseases, Gastrointestinal Diseases
Monterrey, Nuevo León, Mexico
View Trial DetailsNCT04472364
Digestive System Diseases, Gastrointestinal Diseases
Berlin, Germany
View Trial Details